LONDON AstraZeneca is increasing stockpiles of those medicines in Britain and Europe that could be affected by Brexit by around 20 percent, in preparation for potential disruption if the UK crashes out of the EU without a deal.
- Bill Gates backs $30 million push for early Alzheimer's diagnostics
- U.N. says global fight against AIDS is at 'precarious point'
- Abbott Labs tops profit estimates, raises full-year earnings forecast
- Hikma raising injectable opioids output to help ease shortage at U.S. hospitals
- Pfizer-Lilly pain drug meets late-stage trial goals
SOFIA Hundreds of farmers from around Bulgaria rallied in the capital Sofia on Wednesday against the government-ordered mass slaughter of livestock following the first outbreak in the European Union of the highly contagious Peste des Petits Ruminants (PPR).
JERUSALEM Three multinational companies have received an Israeli government grant of 120 million shekels ($33 million) aimed at boosting the presence of large companies and establishing Israel as a hub in biotechnology and medicine.
LONDON A common blood pressure and heart drug manufactured in bulk by a Chinese company and sold worldwide may have contained an impurity linked to cancer since 2012, European regulators said on Tuesday.
A federal judge ruled on Monday against birth control organizations that sought to block the Trump administration from shifting a federal family-planning grant program toward prioritizing groups that are faith-based and counsel abstinence.